文献速递眼底病与葡萄膜炎神经眼科

美国梅毒性葡萄膜炎相关住院发病率上升

Rising Incidence of Syphilitic Uveitis-Related Hospitalizations in the US.
PubMed 文献 · JAMA Ophthalmol · 2024-01-01

这项回顾性横断面研究利用全国住院患者样本分析了2010至2019年美国梅毒性葡萄膜炎相关住院情况,估计共有5581例次住院,全国发病率从2011年每10万人0.08升至2019年0.23(P = .04),四个地理区域均呈上升趋势。作者建议临床医生在评估眼内炎症患者时保持对梅毒的高度怀疑。

要点

  • 2010至2019年美国梅毒性葡萄膜炎相关住院估计5581例次,全国发病率从2011年每10万人0.08升至2019年0.23(P = .04)。
  • 梅毒性葡萄膜炎患者中78.9%(4395例)为男性,32%(1787例)为非洲裔美国人,38.8%(2163例)属于最低收入四分位组。
  • 23.2%(1293例)的梅毒性葡萄膜炎住院患者合并艾滋病。

核心结论

  • 尽管这项横断面研究仅捕获住院诊断,但观察到2010至2019年美国梅毒性葡萄膜炎相关住院发病率上升。
  • 鉴于同时存在全国注射用青霉素G短缺,结果提示临床医生在评估眼内炎症患者时应保持对梅毒的高度怀疑。

研究设计与样本

  • 这项回顾性横断面研究查询全国住院患者样本,纳入2010至2019年美国所有诊断为梅毒、葡萄膜炎和/或梅毒性葡萄膜炎的住院患者。
  • 研究分析了444674例患者的住院数据(中位[IQR]年龄53[37-67]岁;54.8%为男性),统计分析了2023年6月进行。

主要发现

  • 10年研究期间估计有5581例次梅毒性葡萄膜炎相关住院;梅毒性葡萄膜炎患者的中位(IQR)年龄为45(35-55)岁,4395例(78.9%)为男性。
  • 梅毒性葡萄膜炎不成比例地影响非洲裔美国人(1787例[32%],而他们占人口的13.6%)和最低家庭收入四分位组人群(2163例[38.8%])。
  • 全国发病率为每10万人0.15,呈逐年上升趋势,2011年最低(每10万人0.08),2019年最高(每10万人0.23;P = .04)。
  • 区域分析显示美国全部4个地理区域发病率均上升。
  • 共有1293例(23.2%)合并艾滋病。

临床怎么用

  • 作者建议临床医生在评估眼内炎症患者时应保持对梅毒的高度怀疑。

局限性

  • 这项横断面研究仅捕获住院诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The number of syphilis cases continues to increase in the US every year since 2001 with a 74% increase observed since 2017. In addition, there remains a national shortage of injectable penicillin G. Despite the increase in reported cases, to the authors' knowledge, there has been no recent nationwide study investigating the trends in incidence of syphilitic uveitis. OBJECTIVE: To evaluate the national and regional incidence of syphilitic uveitis-related hospitalizations in the US. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective, cross-sectional study. The Nationwide Inpatient Sample was queried to identify all inpatient admissions with a diagnosis of syphilitic uveitis in the US between the years 2010 and 2019. Analyses were performed to determine baseline sociodemographic characteristics and identify national and regional trends in incidence. All patients hospitalized with a diagnosis of syphilis, uveitis, and/or syphilitic uveitis were eligible for inclusion. Statistical analysis of study data took place in June 2023. EXPOSURE: Diagnosis of syphilis, uveitis, and/or syphilitic uveitis on inpatient admissions during the years 2010 to 2019 in the Nationwide Inpatient Sample. MAIN OUTCOME MEASURES: The primary outcome was to determine trends in the national and regional incidence of syphilitic uveitis-related hospitalizations in the US. Secondary outcome measures included sociodemographic characteristics of patients with syphilitic uveitis, incidence stratified by sex and race and ethnicity, and median charge per syphilitic uveitis hospital admission. RESULTS: From the Nationwide Inpatient Sample, inpatient data from 444 674 patients (median [IQR] age, 53 [37-67] years; 54.8% male) were analyzed. There were an estimated 5581 syphilitic uveitis-related hospitalizations during the 10-year study period. The median (IQR) age of individuals with syphilitic uveitis was 45 (35-55) years, and 4395 patients (78.9%) were male. Syphilitic uveitis disproportionately affected African American individuals (1787 patients [32%], although they compose 13.6% of the population) and those belonging to the lowest median household income quartile (2163 [38.8%]). The national incidence was 0.15 per 100 000 population and showed an increasing trend over the years, with the lowest incidence in 2011 (0.08 per 100 000 population) and the highest incidence in 2019 (0.23 per 100 000 population; P = .04). Regional analysis showed an increase in incidence across all 4 US geographical regions. A total of 1293 patients (23.2%) had comorbid AIDS. CONCLUSION AND RELEVANCE: Although this cross-sectional study only captured inpatient diagnosis, an increasing incidence of syphilitic uveitis-related hospitalizations was observed in the US between 2010 and 2019. Given the concomitant national shortage of injectable penicillin G, results suggest that clinicians should maintain a high index of suspicion for syphilis when evaluating patients with intraocular inflammation.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mir TA, Kim SJ, Fang W, et al. Rising Incidence of Syphilitic Uveitis-Related Hospitalizations in the US. JAMA Ophthalmol. 2024. PMID: 37991790. doi:10.1001/jamaophthalmol.2023.5386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。